GRIFULVIN V Drug Patent Profile
✉ Email this page to a colleague
When do Grifulvin V patents expire, and what generic alternatives are available?
Grifulvin V is a drug marketed by Johnson And Johnson, Valeant Luxembourg, and J And J. and is included in four NDAs.
The generic ingredient in GRIFULVIN V is griseofulvin, microsize. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the griseofulvin, microsize profile page.
Summary for GRIFULVIN V
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Clinical Trials: | 2 |
Patent Applications: | 109 |
Formulation / Manufacturing: | see details |
DailyMed Link: | GRIFULVIN V at DailyMed |
Recent Clinical Trials for GRIFULVIN V
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Actavis Inc. | Phase 1 |